⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 6, 2017Expert Review of Clinical ImmunologyOpen Access

Treatment optimization in multiple sclerosis: how do we apply emerging evidence?

Tjalf Ziemssen Katja Thomas

View Full Paper

Ask AI

Bookmark

Share

Abstract

In the past years, the introduction of highly effective treatments has considerably expanded treatment options in relapsing remitting multiple sclerosis (RRMS). Not only the number of available tre...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ziemssen et al. (2017) studied this question.

synapsesocial.com/papers/6a7250f6f44fa9f079dfd731 https://doi.org/10.1080/1744666x.2017.1292135

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Hypermobility spectrum disorder/hypermobile Ehlers-Danlos syndrome, mast cell activation syndrome and dysautonomia as risk factors for adverse events and complicationsExpert Review of Clinical Immunology · Thu,
2How well do we understand the link between fetal hematopoiesis and susceptibility to immune dysfunction?Expert Review of Clinical Immunology · Thu,
3Calreticulin and myeloproliferative neoplasms: linking biology to targeted therapiesExpert Review of Clinical Immunology · Tue,
4Distinguishing the endotypes of Chronic rhinosinusitis: the emerging roles of macrophagesExpert Review of Clinical Immunology · Thu,
5The science-to-practice gap in allergology: a critical appraisal of determinants and knowledge-translation strategies across health systemsExpert Review of Clinical Immunology · Tue,

More from Expert Review of Clinical Immunology

Molecular HLA matching in kidney transplantation: the emerging role of eplet mismatch analysisWed,
Donidalorsen for the treatment of hereditary angioedemaFri,
Novel understanding in diagnosis and management of exercise-induced bronchoconstrictionFri,
The therapeutic potential of GLP-1 receptor agonists in central nervous system diseases: immune cell modulation and neuroinflammationThu,
Parvovirus B19 and inflammatory arthritis: from viral mimicry to infection-associated autoimmunityThu,